Black Patients Die Earlier after Surgery for Esophageal Cancer Andrea S. Wolf, MD, MPH, Emanuela Taioli MD, PhD, Marlene Camacho-Rivera, ScD, MPH, Andrew.

Slides:

Advertisements

Similar presentations

Neoadjuvant Chemotherapy in Malignant Peripheral Nerve Sheath Tumors Elizabeth Shurell, M.D., M.Phil. UCLA General Surgery Resident Research Fellow, Division.

Advertisements

April 25 Exam April 27 (bring calculator with exp) Cox-Regression

¡Celebremos La Salud!: A cancer prevention program for Hispanic and non-Hispanic White women living in a rural area Silvia Tejeda, MPH Doctoral Candidate.

Giving Induction Radiation in Addition to Chemotherapy Is Not Associated with Improved Survival of NSCLC Patients with Operable Mediastinal Nodal Disease.

Cancer and Minorities Norma Kanarek, MPH, PhD Department of Environmental Health Sciences, Johns Hopkins Bloomberg School of Public Health Department of.

Pier Luigi Filosso, MD University of Torino, Department of Thoracic Surgery The Impact of Adjuvant Chemotherapy in Pulmonary Large Cell Neuroendocrine.

A Propensity-matched Study of Lobectomy Versus Segmentectomy for Radiologically Pure Solid Small-sized Non-small Cell Lung Cancer Terumoto Koike 1, Seijiro.

Disparities in Cancer September 22, Introduction Despite notable advances in cancer prevention, screening, and treatment, a disproportionate number.

The influence of Breast Cancer Pay for Performance Initiatives on breast cancer survival and performance measures: a pilot study in Taiwan Raymond NC Kuo,

Introduction DCDOH supports HIV test and treat activities - increased number of HIV tests performed, emphasis on earlier linkage to care. Limited data.

INTRODUCTION  The majority of clinical trials addressing outcomes in limited- stage small cell lung cancer (LS-SCLC) following definitive chemoradiotherapy.

Ethnic Disparities in Early Breast Cancer Management among Asian Americans and Pacific Islanders Rebecca P. Gelber, MD, MPH Department of Medicine, University.

Racial Disparities in Antiretroviral Therapy Use and Viral Suppression among Sexually Active HIV-infected Men who have Sex with Men— United States, Medical.

Skull Base Chordoma and Chondrosarcoma: Changes in National Radiotherapy Patterns and Survival Outcomes Henry S. Park, MD, MPH; Kenneth B. Roberts, MD;

Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.

INCIDENCE AND SURVIVAL TRENDS OF COLORECTAL CANCER FROM 2002 TO 2011 BE Ansa; E Alema-Mensah; MD Claridy; JQ Sheats; B Fontenot, and SA Smith Georgia Regents.

Background  Reports of long-term survivors (≥5 years) of locally advanced esophageal cancer (LAEC) have focused mainly on HRQL or GI symptoms  Only.

“The African American Prostate Cancer Crisis in Numbers”

Influence of Comorbid Depression and Antidepressant Treatment on Mortality for Medicare Beneficiaries with Chronic Obstructive Pulmonary Disease by SSDI-eligibility.

Is surgical resection justified for myasthenia gravis? Long-term results in over 1000 cases. Andrew J. Kaufman, MD; Justin Palatt, MD; Mark Sivak, MD,

SEER Provided Data Mohammad Afnan Baqai 12/3/2009.

Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.

Effect of preoperative concurrent chemoradiotherapy on survival of patients with resectable esophageal or esophagogastric junction cancer: Results from.

Ductal Carcinoma in Situ with Microinvasion: Prognostic Implications, Long-term Outcomes, and Role of Axillary Evaluation Rahul R. Parikh, MD 1, Bruce.

Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.

Prostate Cancer Outcomes by Race & Treatment Site Can-lan Sun MD PhD, Smita Bhatia MD MPH, Lennie Wong PhD, Gail Washington DNS, Karen Nielsen-Menicucci.

Evidence for a Survival Benefit Conferred by Adjuvant Radiotherapy in a Cohort of 608 Women with Early-stage Endometrial Cancer O. Kenneth Macdonald 1,

THE EFFECT OF AGE ON OUTCOME OF SYNOVIAL SARCOMA PATIENTS A DUTCH POPULATION BASED STUDY Myrella Vlenterie, SEJ Kaal, VKY Ho, R Vlenterie, WTA van der.

Adjuvant Radiation is Not Associated with Improved Survival in Patients with Positive Margins Following Lobectomy for Stage I & II Non-Small Cell Lung.

F UNCTIONAL L IMITATIONS IN C ANCER S URVIVORS A MONG E LDERLY M EDICARE B ENEFICIARIES Prachi P. Chavan, MD, MPH Epidemiology PhD Student Xinhua Yu MD.

Treatment Patterns in the Management of Prostate Cancer: Lessons Learned from the Florida Cancer Data System Vonetta L. Williams, PhD, MPH, CTR June 23,

GEOGRAPHIC DISTRIBUTION OF BREAST CANCER IN MISSOURI, Faustine Williams, MS., MPH, Stephen Jeanetta, Ph.D. Department of Rural Sociology, Division.

National Cancer Intelligence Network Outcome and the effect of age in 1318 patients with synovial sarcoma: Report from the National Cancer Intelligence.

Nabhan C et al. Proc ICML 2013;Abstract 102.

Using SEER-Medicare Data to Enhance Registry Data to Assess Quality of Care Joan Warren Applied Research Program National Cancer Institute NAACCR June.

Response to Antiretroviral Treatment In an Ethiopian Hospital Samuel Hailemariam, MD, MPH; J Allen McCutchan, MD, MSc Meaza Demissie, MD, PMH, PHD; Alemayehu.

Premature deaths due to Prostate Cancer: The Role of Diagnosis and Treatment Appathurai Balamurugan MD, MPH S William Ross MD Chris Fisher, BS Jim Files,

Sex-specific trends in lung cancer incidence and survival : a population study of cases 호흡기 내과 R3 조주희 Thorax 2011;66: Camilla M T Sagerup,

Cervical cancer among Asian subgroups in California, Janet Bates, MD MPH California Cancer Registry NAACCR Annual Meeting Denver, Colorado June.

What does the data tell us? Colorectal CANCER IN NEVADA

Perioperative Complications after Neoadjuvant Chemoradiation for Locally-Advanced Esophageal Cancer: A Comparison of Platinum/5-FU and Carboplatin/Paclitaxel.

Prognostic significance of tumor subtypes in male breast cancer:

Impact of Socio-Demographic Factors on Hepatitis C Screening Among Individuals Born Between 1945 and 1965 Madhuri Chandnani MD, Mohamed Barakat MD, Michael.

Factors Influencing Prostate Cancer Treatment Decisions for African American and White Men: Prostate Cancer Follow Back Study Keith Elder, MPA,MPH, PhD.

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes Meng S. Shao, MD, Andrew T. Wong, MD,

Meta-Analysis of Survival After Pleurectomy Decortication Versus Extrapleural Pneumonectomy in Mesothelioma Emanuela Taioli, MD, PhD, Andrea S. Wolf,

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

Emanuela Taioli, MD, PhD, Andrea S

Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic.

Brendon M. Stiles, MD, Farooq Mirza, MD, Jeffrey L. Port, MD, Paul C

Andrea S. Wolf, MD, MPH, Scott J

Aaron P. Thrift, PhD Clinical Gastroenterology and Hepatology

Shawn L Fultz, MD MPH VACS Scientific Meeting, Feb 2004

Outcomes for Thoracoscopy Versus Thoracotomy Not Just Technique Dependent: A Study of 9,787 Patients Andrea Wolf, MD, MPH, Bian Liu, PhD, Emanuele Leoncini,

Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome Emanuela Taioli, MD, PhD, Philip Kent Paschal, Bian Liu, PhD, Andrew.

Andrew P. Dhanasopon, MD, Michelle C. Salazar, MD, Jessica R

Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases Paul C. Lee, MD, Jeffrey L. Port, MD, Subroto.

Baseline measure of health-related quality of life (Functional Assessment of Cancer Therapy-Esophagus) is associated with overall survival in patients.

Melissa Herrin, Jan Tate ScD, MPH & Amy Justice, MD, PhD

Appropriateness of Surgical Approach in Black Patients with Lung Cancer—15 Years Later, Little Has Changed Emanuela Taioli, MD, PhD, Raja Flores, MD

Characteristics of Malignant Pleural Mesothelioma in Women

GOCS GRUPO ONCOLÓGICO COOPERATIVO DEL SUR

NAACCR/IACR Combined Annual Conference 6/11/2019, Vancouver, Canada

NAACCR/IACR Combined Annual Conference 2019

Trends in survival from metastatic lung cancer in California,

Receipt of Adjuvant Endometrial Cancer Treatment According to Race NRG Oncology/Gynecologic Oncology Group (GOG) 210 Study Ashley Felix, PhD, MPH Assistant.

Arti Parikh-Patel, PhD MPH Cyllene Morris, DVM MPVM

Colorectal cancer survival disparities in California

South Carolina Statewide Cancer Prevention & Control Program

Alexander H. Moskovitz, MD, Nabil P

Presentation transcript:

Black Patients Die Earlier after Surgery for Esophageal Cancer Andrea S. Wolf, MD, MPH, Emanuela Taioli MD, PhD, Marlene Camacho-Rivera, ScD, MPH, Andrew Kaufman, MD, Dong-Seok Lee, MD, Faiz Bhora, MD, Raja M. Flores, MD Department of Thoracic Surgery The Icahn School of Medicine at Mount Sinai The Mount Sinai Health System New York, NY

No financial disclosures

Introduction Esophageal cancer in black patients  Higher incidence and mortality  Higher rate of squamous cell CA  Lower use of surgery  When adjusted for surgery, no difference in survival

Objective To determine whether race affects short and long-term mortality in patients having surgery for esophageal cancer using SEER

Methods SEER Inclusion: Blacks, Whites Adenocarcinoma, SCC Exclusion: Distant metastases Cervical esophageal CA

Methods Cox proportional hazards model Outcome: Overall survival Predictors: Race Age Sex Year of dx Stage Cancer-directed surgery Radiation

Baseline characteristics VariableCategories Whites (n = 13,678) Blacks (n = 2,894) p-value SexMale10,168 (74%)2,079 (72%)0.005 Female3,510 (26%)815 (28%) Mean age in yr (95% CI) 67.8 ( )61.6 ( )< Overall Stage Localized6,609 (48%)1,508 (52%)< Regional7,069 (52%)1,386 (48%) Histology SCC6,775 (50%)2,777 (96%)< Adenocarcinoma6,903 (50%)117 (4%) Cancer-directed surgery No6,428 (47%)1,726 (60%)< Yes7,250 (53%)1,168 (40%) Radiation No4,960 (36%)935 (32%)< Yes8,476 (62%)1,870 (65%) Unknown242 (2%)89 (3%) Therapy None 1,619 (12%)411 (14%) < Surgery only 3,341 (25%)524 (19%) Radiation only 4,678 (35%)1,258 (45%) Both surgery and radiation 3,798 (28%)612 (22%)

Incidence over time

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI) Race Black versus White1.24 ( )1.21 ( )1.06 ( ) SexFemale versus Male 0.95 ( )0.94 ( )0.97 ( ) AgePer increased year 1.02 ( )1.01( )1.02 ( ) Stage Regional versus Localized 1.60 ( )1.48 ( )1.78 ( ) Histology SCC versus AC1.22 ( ) -- TherapyNone 1.0 (REF) Surgery only0.30 ( )0.31 ( )0.27 ( ) Radiation only0.56 ( )0.53 ( )0.63 ( ) Both surgery and radiation 0.34 ( )0.36 ( )0.30 ( ) Year of Diagnosis Per increased year 0.97 ( )0.97 ( )0.96 ( )

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI) RaceBlack versus White 1.24 ( )1.21 ( )1.06 ( )

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI) StageRegional versus Localized 1.60 ( )1.48 ( )1.78 ( )

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI) HistologySCC versus AC1.22 ( )--

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI) Therapy None1.0 (REF) Surgery only0.30 ( )0.31 ( )0.27 ( ) Radiation only0.56 ( )0.53 ( )0.63 ( ) Both surgery and radiation 0.34 ( )0.36 ( )0.30 ( )

Localized esophageal cancer

Treated with surgery

Without treatment

Localized esophageal cancer SurgeryNo treatment

Treated with surgery

Conclusions Black race is independently associated with higher mortality in esophageal cancer Black patients treated with surgery have poorer survival than Whites Racial difference in mortality most pronounced at first year

Future directions Differences in how black and white patients are being selected for surgery? Racial disparities in access to dedicated thoracic surgeons doing safe esophagectomies at high volume centers? Disparities in treatment at cancer centers with coordinated multi-disciplinary care?

Thank You

Baseline Characteristics VariableCategories Whites (n = 13,678) Blacks (n = 2,894) p-value SexMale10,168 (74%)2,079 (72%)0.005 Female3,510 (26%)815 (28%) Mean age in yr (95% CI) 67.8 ( )61.6 ( )< Overall Stage Localized6,609 (48%)1,508 (52%)< Regional7,069 (52%)1,386 (48%) Histology SCC6,775 (50%)2,777 (96%)< Adenocarcinoma6,903 (50%)117 (4%) Cancer-directed surgery No6,428 (47%)1,726 (60%)< Yes7,250 (53%)1,168 (40%) Radiation No4,960 (36%)935 (32%)< Yes8,476 (62%)1,870 (65%) Unknown242 (2%)89 (3%) Therapy None 1,619 (12%)411 (14%) < Surgery only 3,341 (25%)524 (19%) Radiation only 4,678 (35%)1,258 (45%) Both surgery and radiation 3,798 (28%)612 (22%)

Cox model 1-year mortality OverallSCCAC Variable Adjusted HR (95% CI)* RaceBlack versus White 1.24 ( )1.21 ( )1.06 ( ) SexFemale versus Male 0.95 ( )0.94 ( )0.97 ( ) AgePer increased year 1.02 ( )1.01( )1.02 ( ) StageRegional versus Localized 1.60 ( )1.48 ( )1.78 ( ) HistologySCC versus AC 1.22 ( ) -- TherapyNone 1.0 (REF) Surgery only 0.30 ( )0.31 ( )0.27 ( ) Radiation only 0.56 ( )0.53 ( )0.63 ( ) Both surgery and radiation 0.34 ( )0.36 ( )0.30 ( ) Year of Diagnosis Per increased year 0.97 ( )0.97 ( )0.96 ( )

Cox model 3-year mortality OverallSCCAC Variable Adjusted HR (95% CI)* RaceBlack versus White 1.24 ( )1.22 ( )1.09 ( ) SexFemale versus Male 0.94 ( )0.91 ( )0.98 ( ) AgePer increased year 1.01 ( ) 1.02 ( ) StageRegional versus Localized 1.67 ( )1.47 ( )1.90 ( ) HistologySCC versus AC 1.15 ( ) -- TherapyNone 1.0 (REF) Surgery only 0.33 ( )0.37 ( )0.29 ( ) Radiation only 0.64 ( )0.59 ( )0.74 ( ) Both surgery and radiation 0.42 ( )0.42( )0.41 ( ) Year of Diagnosis Per increased year 0.97 ( )0.97 ( )0.96 ( )

Cox model overall mortality OverallSCCAC Variable Adjusted HR (95% CI)* RaceBlack versus White 1.25 ( )1.23 ( )1.04 ( ) SexFemale versus Male 0.91 ( )0.89 ( )0.98 ( ) AgePer increased year 1.02 ( )1.01( )1.02 ( ) StageRegional versus Localized 1.60 ( )1.44 ( )1.78 ( ) HistologySCC versus AC 1.13 ( ) -- TherapyNone 1.0 (REF) Surgery only 0.37 ( )0.40 ( )0.33 ( ) Radiation only 0.69 ( )0.64 ( )0.79 ( ) Both surgery and radiation 0.47 ( )0.47( )0.47 ( ) Year of Diagnosis Per increased year 0.97 ( )0.98 ( )0.96 ( )